AURUM BIOSCIENCES LIMITED

SC387903
Active Glasgow

Research and experimental development on biotechnology

4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

AURUM BIOSCIENCES LIMITED

SC387903

Research and experimental development on biotechnology

Founded 1 Nov 2010 Active Glasgow, Scotland 4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 17 Dec 2025 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 21 Sept 2025 Next due 21 Sept 2026 3 months remaining
Net assets £-609K £93K 2024 year on year
Total assets £1M £384K 2024 year on year
Total Liabilities £2M £477K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Imaging Centre Of Excellence Queen Elizabeth University Hospital Langlands Drive Glasgow G51 4LB Scotland

Email

info@example.com

Website

www.example.com

Full company profile for AURUM BIOSCIENCES LIMITED (SC387903), an active life sciences and medical technology company based in Glasgow, Scotland. Incorporated 1 Nov 2010. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type small
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

£741.50k

Increased by £194.75k (+36%)

Net Assets

-£608.64k

Decreased by £93.39k (-18%)

Total Liabilities

£1.83M

Increased by £476.96k (+35%)

Turnover

N/A

Employees

4

Decreased by 1 (-20%)

Debt Ratio

150%

Decreased by 12 (-7%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 1Oct 2020Private Equity
Investor 2Oct 2020Private Equity, Series A
Investor 3Oct 2020Private Equity

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 1,639,879 Shares £1.41m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Jan 2024463,741£398k£0.857
18 Jan 2024385,831£331k£0.857
25 Sept 2020677,467£581k£0.857
25 Sept 2020112,840£97k£0.857

Officers

Officers

2 active 1 resigned
Status
Celestine SantoshDirectorBritishScotland6617 Feb 2023Active
Chavada, Govindsinh, DrDirectorBritishUnited Kingdom4725 Sept 2020Active

Shareholders

Shareholders (41)

Scottish Enterprise
17.9%
710,420
Celestine Santosh
12.3%
488,793

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Scottish Enterprise

Unknown

Active
Notified 25 Sept 2020
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
21 Sept 2025Confirmation StatementConfirmation statement made on 7 Sept 2025 with updates
8 Sept 2025CapitalAllotment of shares (GBP 390.1195) on 30 Aug 2025
8 Sept 2025CapitalAllotment of shares (GBP 386.1531) on 30 Aug 2025
8 Sept 2025CapitalAllotment of shares (GBP 396.8278) on 30 Aug 2025
17 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

21 Sept 2025 Confirmation Statement

Confirmation statement made on 7 Sept 2025 with updates

8 Sept 2025 Capital

Allotment of shares (GBP 390.1195) on 30 Aug 2025

8 Sept 2025 Capital

Allotment of shares (GBP 386.1531) on 30 Aug 2025

8 Sept 2025 Capital

Allotment of shares (GBP 396.8278) on 30 Aug 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2025

6 months ago on 17 Dec 2025

Confirmation statement made on 7 Sept 2025 with updates

9 months ago on 21 Sept 2025

Allotment of shares (GBP 390.1195) on 30 Aug 2025

9 months ago on 8 Sept 2025

Allotment of shares (GBP 386.1531) on 30 Aug 2025

9 months ago on 8 Sept 2025

Allotment of shares (GBP 396.8278) on 30 Aug 2025

9 months ago on 8 Sept 2025